Democratic Republic of Congo vs Nigeria: HIV positive pregnant women receiving antiretrovirals … high
HIV positive pregnant women receiving antiretrovirals … high over time
- Democratic Republic of Congo
- Nigeria
How they compare
Nigeria currently reports 21.0% against 11.0% in Democratic Republic of Congo, a difference of 10.0%.
That makes Nigeria's figure about 1.9 times Democratic Republic of Congo's.
The two have swapped places 1 time across 5 shared years of data; in 2004 it was Democratic Republic of Congo ahead.
Democratic Republic of Congo ranks 35th and Nigeria ranks 32nd of 38 countries.
Nigeria has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher hiv positive pregnant women receiving antiretrovirals, using, Democratic Republic of Congo or Nigeria?
- Nigeria, at 21.0% against 11.0% in Democratic Republic of Congo as of 2011.
- What is the difference in hiv positive pregnant women receiving antiretrovirals, using between Democratic Republic of Congo and Nigeria?
- 10.0%, with Nigeria ahead.
- How many years of comparable data are there for Democratic Republic of Congo and Nigeria?
- 5 years are reported by both, from 2004 to 2009.
- How do Democratic Republic of Congo and Nigeria rank globally for hiv positive pregnant women receiving antiretrovirals, using?
- Democratic Republic of Congo ranks 35th and Nigeria ranks 32nd of 38 countries.
- Where does this data come from?
- http://data.unaids.org/pub/GlobalReport/2008/, published as HIV positive pregnant women receiving antiretrovirals, using WHO/UNAIDS methodology (%; high estimate). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of HIV-infected pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission. Numerator: Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission. Denominator: Estimated number of HIV-infected pregnant women in the last 12 months. Ranges are presented for countries with low and concentrated epidemics. The purpose of this indicator is to assess progress in preventing vertical transmission of HIV. All data reflect values representing 12 month period ending December 2007 which have been reconciled between reporting country and UNAIDS/WHO/UNICEF, unless otherwise noted. All analysis of this indicator, including quoted country figures, reflect numerators which have gone through a tri agency reconciliation (UNAIDS/WHO/UNICEF) process and denominators which have been estimated directly from the UNAIDS/WHO Reference group on Estimates, Modelling and Projections methodology (Spectrum). The reconciliation process ensured all agencies reported the same country endorsed figure which was the most recent and met the definition of HIV-infected women receiving antiretroviral drugs over the last 12 months, and thus reflect a full year. Every effort was made in cases of discrepancy across the three agencies to obtain approval from the country on a final indicator value.